CVS Ducks Sentry Data's Antitrust Claim, For Now

By Matthew Perlman (August 28, 2018, 4:52 PM EDT) -- A Florida federal judge on Tuesday dismissed an antitrust claim from Sentry Data Systems Inc. alleging CVS is unlawfully forcing health care providers to use its 340B Drug Pricing Program administrator Wellpartner LLC, but left intact allegations the pharmacy giant misappropriated trade secrets to steal customers.

U.S. District Judge Beth Bloom issued an order partially granting CVS Pharmacy Inc.'s motion to dismiss, nixing a Sherman Act claim that alleged it used its market power as a pharmacy to force providers participating in the federal 340B program to use its own administrator rather than competitors like Sentry. The judge found that while...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.

  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!


Attached Documents

Related Sections

Case Information

Case Title

Subscribers Only

Case Number

Subscribers Only


Subscribers Only

Nature of Suit

Subscribers Only


Subscribers Only

Date Filed

Subscribers Only

Law Firms


Judge Analytics

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!